JP2013506672A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013506672A5 JP2013506672A5 JP2012532138A JP2012532138A JP2013506672A5 JP 2013506672 A5 JP2013506672 A5 JP 2013506672A5 JP 2012532138 A JP2012532138 A JP 2012532138A JP 2012532138 A JP2012532138 A JP 2012532138A JP 2013506672 A5 JP2013506672 A5 JP 2013506672A5
- Authority
- JP
- Japan
- Prior art keywords
- prv
- immunogenic composition
- polypeptide
- seq
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24805809P | 2009-10-02 | 2009-10-02 | |
| US61/248,058 | 2009-10-02 | ||
| US32504710P | 2010-04-16 | 2010-04-16 | |
| US61/325,047 | 2010-04-16 | ||
| US38059410P | 2010-09-07 | 2010-09-07 | |
| US61/380,594 | 2010-09-07 | ||
| PCT/US2010/051346 WO2011041789A1 (en) | 2009-10-02 | 2010-10-04 | Piscine reovirus immunogenic compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013506672A JP2013506672A (ja) | 2013-02-28 |
| JP2013506672A5 true JP2013506672A5 (https=) | 2013-11-21 |
Family
ID=43826692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012532138A Pending JP2013506672A (ja) | 2009-10-02 | 2010-10-04 | 魚類レオウイルス免疫原性組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US9366667B2 (https=) |
| EP (2) | EP2482824B1 (https=) |
| JP (1) | JP2013506672A (https=) |
| CN (1) | CN102647988A (https=) |
| CA (2) | CA2776386C (https=) |
| CL (5) | CL2012000821A1 (https=) |
| DK (1) | DK179132B1 (https=) |
| WO (2) | WO2011041789A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2482824B1 (en) * | 2009-10-02 | 2016-11-30 | The Trustees of Columbia University in the City of New York | Piscine reovirus immunogenic compositions |
| WO2015028565A1 (en) * | 2013-08-30 | 2015-03-05 | Veterinærinstituttet | Method for propagating a virus |
| IL230970A0 (en) | 2014-02-13 | 2014-09-30 | Univ Ramot | Tilapia virus vaccines |
| CL2015000980A1 (es) * | 2014-04-18 | 2016-07-01 | Upstartdna Co Ltd Standard Entity | Métodos para detectar patógenos en peces de agua fría. |
| WO2015185605A1 (en) * | 2014-06-03 | 2015-12-10 | Veterinærinstituttet | New reovirus infecting rainbow trout |
| WO2016075277A1 (en) | 2014-11-14 | 2016-05-19 | Patogen Analyse As | Novel fish virus and method for detection |
| CN107427570A (zh) | 2014-12-15 | 2017-12-01 | 纽约市哥伦比亚大学理事会 | 新型罗非鱼病毒及其用途 |
| CA3083873A1 (en) | 2017-12-06 | 2019-06-13 | Intervet International B.V. | Use of a non-structural protein from prv to protect against heart and skeletal muscle inflammation |
| WO2020069658A1 (zh) * | 2018-10-05 | 2020-04-09 | 福又达生物科技股份有限公司 | 鱼病原体检测方法 |
| US10688050B1 (en) | 2018-12-21 | 2020-06-23 | Synthon B.V. | Pharmaceutical composition comprising ibrutinib |
| NO344967B1 (en) | 2019-01-30 | 2020-08-03 | Patogen As | Piscine Orthoreovirus Virulence Markers |
| CN109971890A (zh) * | 2019-04-30 | 2019-07-05 | 上海海洋大学 | Ii型草鱼呼肠孤病毒的微滴式数字pcr检测试剂盒及其专用引物和探针 |
| CN110079507B (zh) * | 2019-05-06 | 2022-05-20 | 中国海洋大学 | 抗牙鲆黏膜免疫球蛋白IgT的单克隆抗体及其应用 |
| CN110408637B (zh) * | 2019-08-08 | 2020-12-25 | 中国水产科学研究院长江水产研究所 | 一种草鱼出血病酵母口服疫苗及应用 |
| EP4076515A1 (en) | 2019-12-16 | 2022-10-26 | Intervet International B.V. | Inactivated piscine orthoreovirus vaccine |
| NO346211B1 (en) | 2020-07-14 | 2022-04-19 | Patogen As | Piscine Orthoreovirus Virulence Markers |
| CN112206317B (zh) * | 2020-10-12 | 2023-09-22 | 浙江省淡水水产研究所 | 一种草鱼出血病二价核酸菌蜕疫苗的制备方法 |
| CN112048575A (zh) * | 2020-10-26 | 2020-12-08 | 深圳市莱孚生物科技有限公司 | 一种用于鉴定草鱼出血热病毒的引物及探针以及检测方法 |
| CN113527475B (zh) * | 2021-06-07 | 2022-04-29 | 浙江省农业科学院 | 一种分泌鸭新型呼肠孤病毒σC蛋白单抗的杂交瘤细胞、单抗及应用 |
| CN114164159B (zh) * | 2021-06-21 | 2023-10-03 | 湖南师范大学 | 一种具有防治鱼类杀鲑气和迟缓爱德华氏菌感染的二联疫苗及其制备方法与应用 |
| KR102734012B1 (ko) * | 2021-08-19 | 2024-11-25 | 성균관대학교산학협력단 | 바이러스성 출혈성 패혈증 바이러스에 특이적으로 결합하는 항체 또는 이의 항원 결합 단편, 및 이들의 용도 |
| CL2024000227A1 (es) * | 2024-01-25 | 2024-07-12 | Univ Santiago Chile | Proteína de piscine orthoreovirus; composición de vacuna; y su uso. |
| CN118853676B (zh) * | 2024-09-03 | 2025-03-07 | 中国水产科学研究院淡水渔业研究中心 | 一种草鱼ii型呼肠孤病毒反义rna及其重组载体、试剂盒和应用 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
| NZ215865A (en) | 1985-04-22 | 1988-10-28 | Commw Serum Lab Commission | Method of determining the active site of a receptor-binding analogue |
| WO1986006487A1 (en) | 1985-04-22 | 1986-11-06 | Commonwealth Serum Laboratories Commission | Method for determining mimotopes |
| US4737323A (en) | 1986-02-13 | 1988-04-12 | Liposome Technology, Inc. | Liposome extrusion method |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| EP1380651A2 (en) | 1991-08-26 | 2004-01-14 | Baxter Healthcare S.A. | Recombinant fowlpox virus with intact FPV-tk-gene |
| FR2737730B1 (fr) | 1995-08-10 | 1997-09-05 | Pasteur Merieux Serums Vacc | Procede de purification de virus par chromatographie |
| EP1075523B1 (en) | 1998-05-08 | 2007-08-08 | Intervet International BV | Structural proteins of fish pancreatic disease virus and uses thereof |
| US20080256662A1 (en) * | 1999-05-10 | 2008-10-16 | Byrum Joseph R | Nucleic acid molecules and other molecules associated with plants |
| CN1170934C (zh) | 1999-08-03 | 2004-10-13 | 阿克佐诺贝尔公司 | 源自白斑综合征病毒的蛋白质及其应用 |
| AU6304100A (en) | 1999-08-07 | 2001-03-05 | Novartis Ag | Sequence |
| DE60017229D1 (de) | 1999-10-18 | 2005-02-10 | Akzo Nobel Nv | DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen |
| CA2402718C (en) | 2000-03-11 | 2013-06-25 | Novartis Ag | Fish vaccine against piscirickettsia salmonis |
| CA2325088A1 (en) * | 2000-12-01 | 2002-06-01 | Fusogenix Inc. | Novel membrane fusion proteins derived from poikilothermic reovirus |
| CA2456229A1 (en) | 2001-08-03 | 2003-02-13 | Diversa Corporation | Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| US7670604B2 (en) | 2002-12-13 | 2010-03-02 | Aurelium Biopharma, Inc. | Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| EP1585761B1 (en) | 2003-01-20 | 2013-08-21 | Thomas Rudel | L-amino acid oxidase with cytotoxic activity from aplysia punctata |
| CA2570050C (en) | 2004-06-11 | 2013-03-05 | Pharmaq As | Heart and skeletal muscle inflammation (hsmi) virus |
| US7361468B2 (en) * | 2004-07-02 | 2008-04-22 | Affymetrix, Inc. | Methods for genotyping polymorphisms in humans |
| EP1868025A4 (en) | 2005-02-22 | 2010-05-12 | Ngk Insulators Ltd | OPTICAL MODULATOR |
| US8088976B2 (en) | 2005-02-24 | 2012-01-03 | Monsanto Technology Llc | Methods for genetic control of plant pest infestation and compositions thereof |
| JPWO2007020983A1 (ja) * | 2005-08-18 | 2009-02-26 | 独立行政法人科学技術振興機構 | オオムギest配列を利用して作製された二倍体コムギ遺伝地図を用いるコムギの育種方法 |
| DK179025B1 (da) * | 2005-09-16 | 2017-08-28 | Intervet Int Bv | Fiskevaccine |
| KR20100051041A (ko) | 2007-03-07 | 2010-05-14 | 엔벤타 바이오파마슈티칼스 코퍼레이션 | 이중-가닥 봉쇄형 핵산 조성물 |
| JP5577103B2 (ja) | 2007-03-12 | 2014-08-20 | オンコリティクス バイオテク,インコーポレーテッド | 改変配列を有するレオウイルス |
| WO2010024284A1 (ja) * | 2008-09-01 | 2010-03-04 | 国立大学法人 北海道大学 | 魚類抗ウイルスワクチン、魚類免疫賦活剤、および魚類免疫付与方法 |
| EP2482824B1 (en) | 2009-10-02 | 2016-11-30 | The Trustees of Columbia University in the City of New York | Piscine reovirus immunogenic compositions |
-
2010
- 2010-10-04 EP EP10821407.3A patent/EP2482824B1/en active Active
- 2010-10-04 CN CN2010800446027A patent/CN102647988A/zh active Pending
- 2010-10-04 CA CA2776386A patent/CA2776386C/en active Active
- 2010-10-04 WO PCT/US2010/051346 patent/WO2011041789A1/en not_active Ceased
- 2010-10-04 US US13/499,867 patent/US9366667B2/en active Active
- 2010-10-04 EP EP10821408.1A patent/EP2482825B1/en not_active Revoked
- 2010-10-04 WO PCT/US2010/051348 patent/WO2011041790A1/en not_active Ceased
- 2010-10-04 JP JP2012532138A patent/JP2013506672A/ja active Pending
- 2010-10-04 US US13/499,874 patent/US9395356B2/en active Active
- 2010-10-04 CA CA2776534A patent/CA2776534A1/en not_active Abandoned
-
2011
- 2011-05-11 DK DKPA201170227A patent/DK179132B1/en active
-
2012
- 2012-04-02 CL CL2012000821A patent/CL2012000821A1/es unknown
- 2012-04-02 CL CL2012000822A patent/CL2012000822A1/es unknown
-
2013
- 2013-10-10 CL CL2013002907A patent/CL2013002907A1/es unknown
- 2013-10-11 CL CL2013002933A patent/CL2013002933A1/es unknown
-
2016
- 2016-01-29 CL CL2016000240A patent/CL2016000240A1/es unknown
- 2016-06-14 US US15/181,916 patent/US20160287694A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013506672A5 (https=) | ||
| Qi et al. | The humoral response and antibodies against SARS-CoV-2 infection | |
| De Alwis et al. | Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development | |
| Martinez-Flores et al. | SARS-CoV-2 vaccines based on the spike glycoprotein and implications of new viral variants | |
| Yong et al. | Recent advances in the vaccine development against Middle East respiratory syndrome-coronavirus | |
| Chen et al. | Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement | |
| Klasse et al. | Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization | |
| DK201170227A (en) | Piscine reovirus immunogenic compositions | |
| Mahgoub | An overview of infectious bursal disease | |
| Boyoglu-Barnum et al. | Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice | |
| Soy et al. | A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review | |
| JP2017530124A5 (https=) | ||
| JP2019151636A5 (https=) | ||
| O’Ryan | Rotavirus Vaccines: a story of success with challenges ahead | |
| Chen et al. | Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with alum induces protective immunity and reduces immune enhancement | |
| Tan et al. | Vaccine against norovirus | |
| KR101554080B1 (ko) | 1b형 소 바이러스성 설사 바이러스 백신 조성물 및 방법 | |
| Song et al. | Plant‐based, adjuvant‐free, potent multivalent vaccines for avian influenza virus via Lactococcus surface display | |
| Shoja et al. | Rotavirus VP6: involvement in immunogenicity, adjuvant activity, and use as a vector for heterologous peptides, drug delivery, and production of nano-biomaterials | |
| EP2419124A2 (en) | Foot-and mouth disease marker vaccine | |
| Fan et al. | Genotype I of Japanese encephalitis virus virus-like particles elicit sterilizing immunity against genotype I and III viral challenge in swine | |
| Rey et al. | Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice | |
| Soria et al. | Immune response and partial protection against heterologous foot‐and‐mouth disease virus induced by dendrimer peptides in cattle | |
| Lee et al. | Newly emerging human coronaviruses: animal models and vaccine research for SARS, MERS, and COVID-19 | |
| Kochinger et al. | Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection |